<code id='AF7C211BAF'></code><style id='AF7C211BAF'></style>
    • <acronym id='AF7C211BAF'></acronym>
      <center id='AF7C211BAF'><center id='AF7C211BAF'><tfoot id='AF7C211BAF'></tfoot></center><abbr id='AF7C211BAF'><dir id='AF7C211BAF'><tfoot id='AF7C211BAF'></tfoot><noframes id='AF7C211BAF'>

    • <optgroup id='AF7C211BAF'><strike id='AF7C211BAF'><sup id='AF7C211BAF'></sup></strike><code id='AF7C211BAF'></code></optgroup>
        1. <b id='AF7C211BAF'><label id='AF7C211BAF'><select id='AF7C211BAF'><dt id='AF7C211BAF'><span id='AF7C211BAF'></span></dt></select></label></b><u id='AF7C211BAF'></u>
          <i id='AF7C211BAF'><strike id='AF7C211BAF'><tt id='AF7C211BAF'><pre id='AF7C211BAF'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:4569
          Adobe

          Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

          Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

          advertisement

          Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Baby aspirin cuts fat buildup in liver disease patients, in small study
          Baby aspirin cuts fat buildup in liver disease patients, in small study

          PatrickSison/APLow-doseaspirinledtoareductioninliverfatamongpatientswithmetabolic-associatedliverdis

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Virtual Event: March of the Biosimilars

          Editor’snote:Arecordingoftheeventisembeddedbelow.SeveralbiosimilarversionsofHumira,whichforyearshasb